The study aims to investigate postoperative outcomes in terms of intraocular pressure as well as safety measures after two different MIGS implants (MINIject® or Hydrus®) in conjunction with cataract surgery (CS) for patients with chronic glaucoma. The patients will be followed up for 5 years after the date of their implantation. Standard ophthalmologic assessments including measurement of intraocular pressure, fundus examination and ocular imaging with OCT (Optical Coherence Tomography). Assessment of life quality as well as adverse events will be performed.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with glaucoma in which surgery is indicated to reach target intraocular pressure as well as lens opacities where CS is indicated
Clinically eligible for both surgeries
Subjects not anticipated to require any further surgery in the next 12 months
Patients' age \> 18 years
You may not be if
Patients who do not want to make follow-ups at the department